PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Канал маалыматтары
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support c...
Жаңы эпизоддор
496 эпизод
Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Haley A. Moss, MD, MBA / Angeles Alvarez Secord, MD, MHSc - Implementing Immuno-Oncology in Gynecologic Cancer Care for Veterans: Expert Insights on Personalized Treatment
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Tanios Bekaii-Saab, MD - Playing the Right Sequence in mCRC: Practical Strategies for Integrating Multi-Kinase Inhibitors in Later Lines of Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc) - Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jonathan L. Kaufman, MD - The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sameh Gaballa, MD - Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - Leading the Next Chapter of Myeloma Care: Oncology Nurse Stewardship in the Era of Innovative Antibodies and Cellular Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Simron Singh, MD, MPH - Treatment Planning Made CLEAR in Neuroendocrine Tumors and Pancreatic Cancer: Personalized Integration of Validated and Emerging Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Hans Lee, MD - Expanding the Bispecific Option Across Hematologic Cancers: Guidance for the Community on Collaborative Care and Accessing Innovative Immunotherapy for Myeloma and Lymphoma
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. med. Barbara Eichhorst - The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD, Jennifer Woyach, MD - The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Caitlin Costello, MD - The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Samuel Cytryn, MD, Yelena Y. Janjigian, MD* - Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Peter R. Galle - Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Elias Jabbour, MD / Ibrahim Aldoss, MD - ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Heinz-Josef Lenz, MD, FACP - Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Zev A. Wainberg, MD - Hope on the Horizon in Gastric Cancer: Breakthroughs in Personalized Care With Immunotherapy and Targeted Strategies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Arndt Vogel, MD, PhD - Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy and Targeted Platforms
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Patrick Schöffski, MPH / Breelyn A. Wilky, MD - Patient-Centric Frameworks in Desmoid Tumors: Integrating Emerging Science on Gamma Secretase Inhibitors for Progressive Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Navigating the Layers of Complexity in R/R B-Cell Cancers: From Clinical Prognosis to Emerging Therapeutic Prospects in CLL/SLL, MCL, and DLBCL
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Navigating Multifactorial Clinical Decisions in HR+ EBC and MBC: A Case-Based, Algorithmic Guide
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Nitin Jain, MD - C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Naval Daver, MD - Winning GAMBITS Against AML: Guidance on Advances and Medical Breakthroughs with Innovative Targeted Strategies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Shilpa Gupta, MD - Adopting Innovation in Bladder Cancer: Aligning the Evidence on Antibody–Drug Conjugates to Inform Treatment Decisions
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Karim Fizazi, MD, PhD - Mission Possible in Prostate Cancer: Leveraging Genomics, Modern Therapeutics, and Individualized Patient Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sumanta Kumar Pal, MD, FASCO - RCC Treatment Innovations in Practice: Preparing for Individualized Patient Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Hussein Tawbi, MD, PhD - Moving the Efficacy Needle With Immunotherapy in Melanoma: Modern Standards and Next-Gen Strategies in Resectable and Unresectable Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...